These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 20807757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fine mapping of the amyloid β-protein binding site on myelin basic protein.
    Kotarba AE, Aucoin D, Hoos MD, Smith SO, Van Nostrand WE.
    Biochemistry; 2013 Apr 16; 52(15):2565-73. PubMed ID: 23510371
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitro.
    Hoos MD, Ahmed M, Smith SO, Van Nostrand WE.
    Biochemistry; 2009 Jun 09; 48(22):4720-7. PubMed ID: 19385666
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of histidines in amyloid β fibril assembly.
    Brännström K, Islam T, Sandblad L, Olofsson A.
    FEBS Lett; 2017 Apr 09; 591(8):1167-1175. PubMed ID: 28267202
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice.
    Ou-Yang MH, Van Nostrand WE.
    J Neuroinflammation; 2013 Nov 05; 10():134. PubMed ID: 24188129
    [Abstract] [Full Text] [Related]

  • 13. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A, Luheshi LM, Söllvander S, Pereira de Barros T, Macao B, Knowles TP, Biverstål H, Lendel C, Ekholm-Petterson F, Dubnovitsky A, Lannfelt L, Dobson CM, Härd T.
    Proc Natl Acad Sci U S A; 2010 Aug 31; 107(35):15595-600. PubMed ID: 20713699
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF, Howell KG, Olson NC, Ramirez-Alvarado M, Kandimalla KK.
    Biochemistry; 2012 May 15; 51(19):3993-4003. PubMed ID: 22545812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL.
    Protein Eng Des Sel; 2009 Mar 15; 22(3):199-208. PubMed ID: 18927231
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides.
    Naito A, Kawamura I.
    Biochim Biophys Acta; 2007 Aug 15; 1768(8):1900-12. PubMed ID: 17524351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.